Last reviewed · How we verify

NCT03233594

PET Imaging of Chronic Pain Syndromes

Active, enrolled Last updated 25 July 2025
What this trial tests

trial testing Chiropractic Group in Chronic Pain Syndrome in 32 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
7 June 2017
Primary endpoint
1 April 2026
1 April 2026

Quick facts

Lead sponsorThomas Jefferson University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment32
Start date7 June 2017
Primary completion1 April 2026
Estimated completion1 April 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Jefferson University

Who can join

18 and older, any sex, with Chronic Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Central nervous system (CNS) changes associated with pain have been difficult to measure until the development of functional neuroimaging techniques such as positron emission tomography (PET). We have previously observed asymmetry in the thalamus associated with chronic pain that altered during acupuncture therapy. Imaging studies of therapeutic techniques for chronic pain in animals and humans have been quite limited. This study will be the first to utilize FDG PET-MRI imaging of both the brain and body in order to assess CNS changes and peripheral body changes related to chronic pain and its potential management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Pain Syndrome

Currently open trials in the same condition.

Other Thomas Jefferson University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03233594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing